Paoluzzi, Luca <br/><br/>
The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitor.  [electronic resource] 

 -  British journal of haematology  Sep 2009 
 - 656-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2009.07797.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--metabolism<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Cyclin D1--metabolism<br/>Cyproheptadine--administration & dosage<br/>Disease Models, Animal<br/>Histamine H1 Antagonists--pharmacology<br/>Histone Deacetylase Inhibitors<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Mice<br/>Protease Inhibitors--pharmacology<br/>Pyrazines--administration & dosage